Cargando…
Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA
BACKGROUND: Colorectal cancer (CRC) screening can effectively reduce disease-related mortality by detecting CRC at earlier stages. We have previously demonstrated that the presence of SDC2 methylation in stool DNA is significantly associated with the occurrence of CRC regardless of clinical stage. T...
Autores principales: | Han, Yoon Dae, Oh, Tae Jeong, Chung, Tae-Ha, Jang, Hui Won, Kim, Youn Nam, An, Sungwhan, Kim, Nam Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419806/ https://www.ncbi.nlm.nih.gov/pubmed/30876480 http://dx.doi.org/10.1186/s13148-019-0642-0 |
Ejemplares similares
-
Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer
por: Oh, Tae Jeong, et al.
Publicado: (2017) -
Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer
por: Song, Ji Hyeong, et al.
Publicado: (2023) -
Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial
por: Kim, Chang Woo, et al.
Publicado: (2021) -
Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer
por: Su, Wei-Chih, et al.
Publicado: (2021) -
A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA
por: Ma, Liang, et al.
Publicado: (2022)